Gene-therapy United States

Seragon is the top biotech company, optimizing human health and longevity around the world with a progressive approach to biomedical design. We're spearheading the next exciting phase of medical advancements, pioneering significant discoveries in genomic ...

Cell gene therapy 2019 welcomes you all at “International Conference on Cell and Gene Therapy” during September 10-11, 2019 at Prague, Czech Republic. The conference focusses with an exciting Theme on “Exploring the advancements in Cell and Gene Therapy” ...

Canji, Inc. is a biotechnology company engaged in the development of innovative therapeutics based on tumor suppressor genes, cell-cycle regulators and growth modulators. The company,s initial research efforts are focused on the two best-characterized ...

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle ...

LAGeT, Inc. was formed in 2001 and through its subsidiary, LAGeT Musculoskeletal, LLC (the Company) has developed a technology process, termed LAGT (Light Activated Gene Therapy) for articular and meniscal cartilage repair, ligament and tendon healing ...

Cyto Pulse was founded in December 1995 and is incorporated as a regular C corporation in Maryland. The company is composed of a multidisciplinary staff of engineers and scientists. Cyto Pulse develops electric field based devices for use in vaccine delivery ...

INCELL provides contract services to other companies. INCELL has very broad-ranging scientific and management expertise that includes: infectious disease, oncology, cell biology, toxicology, microbiology, neurobiology, gene therapy, immunology, virology ...

Ion Channel Innovations is a development stage biotechnology company formed to develop Ion Channel Therapy (ICT), an innovative gene transfer therapy solution expected to be safe and long-term effective for erectile dysfunction, urinary incontinence, and ...

Adjuvant is a strategic management consulting company. Our consultants have experience working in successful public and start-up firms in the life science, healthcare, and technology markets. We have a unique perspective on today's markets and trends ...

Neurologix, Inc. is engaged in the research and development of treatments for disorders of the brain and central nervous system, primarily utilizing gene therapies. The Company’s technology, which it refers to as NLX, is in the clinical development stages ...

Omnia's mission is to address the process development (PD) and manufacturing needs of both individual investigators and organizations requiring flexible, pre-clinical and Phase I/II GMP manufacturing services for novel biologics. Viral based products and ...

CardioVascular BioTherapeutics, Inc. (Cardio) is a development-stage biopharmaceutical company focused on developing drugs to stimulate the growth of new blood vessels for the treatment of cardiovascular diseases. The active pharmaceutical ingredient (API ...

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos ...

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, GMP/GTP manufacturing, and regulatory compliance, as ...

Discovery Genomics, Inc. (DGI) was founded in 2000 and became operational in January 2002. DGI maintains exclusive rights to two breakthrough technologies that significantly enhance the development of new therapeutics - from gene discovery to treatment ...

Vascular Genetics is a privately held company dedicated to the discovery, development, and rapid commercialization of innovative gene therapies that alleviate or cure serious and life-threatening diseases of the vascular system.

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos ...

Health Care Investment Visions® was founded in 1996 by seasoned, multi-decade veterans of the health care information technology industry whose experience was gained in the often unpredictable health care and technology markets. Originally focused on ...

AnGes MG, Inc. is a biopharmaceutical company founded December 1999 based on an innovative discovery by researchers of Osaka University. We specialize in R&D and practical application of genetic medicine. At present, we are engaged in developing two new ...

Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. Under development are RNAi gene silencing therapies based on Mirus' proprietary Dynamic ...

Applied Genetic Technologies Corporation (AGTC) was founded in January, 1999 by five scientific leaders in the use of viral vectors for Gene Therapy. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application ...

Genovo, Inc., is a privately-held biotechnology company focusing on the design, and early stage clinical development of gene-based therapeutic products for the treatment of human disease. Genovo's product development pipeline includes its internal programs ...

HUMAN GENE THERAPY publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including man. Improvements in vector development, delivery systems, and animal models are covered. Ethical/legal/regulatory ...

Omnia offers an array of manufacturing and process development services for companies engaged in the development of novel biologics. Our experience in many of these areas – from preclinical gene therapeutics through commercial recombinant proteins – gives ...

Ion Channel Innovations is a development stage biotechnology company formed to develop Ion Channel Therapy, an innovative gene transfer therapy solution